Morel A, Hoisnard L, Dudreuilh C, Moktefi A, et al. Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy. Transpl Int 2022;35:10228.
PMID: 35497889